Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michael F. Haller"'
Autor:
Markku Tammi, Wei Jing, Paul L. DeAngelis, Kirsi Rilla, Michael F Haller, Genevieve Bart, Hanna Siiskonen, Riikka Kärnä, Raija Tammi
Publikováno v:
Glycobiology. 23:222-231
Hyaluronan (HA) is a large glycosaminoglycan produced by hyaluronan synthases (HAS), enzymes normally active at plasma membrane. While HA is delivered into the extracellular space, intracellular HA is also seen, mostly in vesicular structures, but th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa69ea9d09ddad784158c28389498f98
https://doi.org/10.1093/glycob/cws149
https://doi.org/10.1093/glycob/cws149
Autor:
Jocelyne Flament, Mark S. Wallace, Jay Thomas, Richard C. Yocum, Daniel Vaughn, Michael F. Haller
Publikováno v:
Journal of Pain and Symptom Management. 38:663-672
Morphine is often administered by the subcutaneous (SC) route when venous access is difficult to achieve. Hyaluronidase temporarily increases the permeability of SC connective tissues by degrading hyaluronan and has been shown to increase the dispers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905dad875d1146b4588b7ef8624c7803
https://doi.org/10.1016/j.jpainsymman.2009.03.009
https://doi.org/10.1016/j.jpainsymman.2009.03.009
Autor:
Michael F. Haller, Patrice Laquerriere, Anthony Z. Faranesh, Monet T. Nastley, Elliot R. McVeigh, Kam W. Leong, Cristina Perez de la Cruz
Publikováno v:
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine, Wiley, 2004, 51, pp.1265-71. 〈10.1002/mrm.20092〉
Magnetic Resonance in Medicine, Wiley, 2004, 51, pp.1265-71. 〈10.1002/mrm.20092〉
A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL-lactic-co-glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68eaa64eefbf6e0e35e2b877b7a4edb3
https://doi.org/10.1002/mrm.20092
https://doi.org/10.1002/mrm.20092
Publikováno v:
Journal of infusion nursing : the official publication of the Infusion Nurses Society. 35(3)
The subcutaneous (SC) route of administration is generally preferred over intravenous administration because it enables at-home injection, improves quality of life, and reduces health care costs. In general, a volume of no greater than 1 to 2 mL is i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::577c2bf91cab3ad82f2cb2a8422e149d
https://pubmed.ncbi.nlm.nih.gov/22498485
https://pubmed.ncbi.nlm.nih.gov/22498485
Publikováno v:
Journal of infusion nursing : the official publication of the Infusion Nurses Society. 35(2)
Despite the growing frequency of intravenous (IV) injections, establishing peripheral IV access is challenging, particularly in patients with small or collapsed veins. Therefore, patients often endure failed attempts and eventually become venous depl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c31f5b77fd71cda11ad9083ee21d99
https://pubmed.ncbi.nlm.nih.gov/22382792
https://pubmed.ncbi.nlm.nih.gov/22382792
Publikováno v:
Journal of pain and symptom management. 38(5)
Morphine is usually given intravenously (IV) for the treatment of moderate-to-severe pain, but subcutaneous (SC) administration is a viable alternative for parenteral delivery. The pharmacokinetics of SC morphine may be enhanced by coadministration w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80aace4b7331cc88759f294e51ac77ba
https://pubmed.ncbi.nlm.nih.gov/19819667
https://pubmed.ncbi.nlm.nih.gov/19819667
Autor:
Catherine Le Visage, Pascal Breton, Nathalie Rioux-Leclercq, Michael F. Haller, Kam W. Leong, Bernard A. Malavaud
Publikováno v:
The Journal of urology. 171(3)
We aimed to promote the efficacy of paclitaxel in intracavitary treatment of superficial transitional cell carcinoma of the bladder by designing bio-adhesive microspheres capable of achieving controlled release of the drug at the urothelium/urine int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a87d91ff9460b6f208b66a6801ca96
https://pubmed.ncbi.nlm.nih.gov/14767342
https://pubmed.ncbi.nlm.nih.gov/14767342
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.